ArticleBMC infectious diseases2025
Age-stratified immune characteristics in central nervous system tuberculosis patients: a comparative T lymphocyte subset analysis within a cohort of 862 extrapulmonary tuberculosis patients.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Immune-inflammatory profiles and disease severity in pulmonary tuberculosis complicated by central nervous system tuberculosis.Frontiers in cellular and infection microbiology · 2026Article
- Age-Stratified Effects of Diabetes Mellitus on Central Nervous System Tuberculosis Risk and Combined Effects with Neutrophil-to-Lymphocyte Ratio.Infection and drug resistance · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCentral nervous system tuberculosis (CNS-TB) remains a critical clinical challenge with high mortality, and its underlying immunopathological mechanisms have not been fully elucidated. This study aimed to investigate age-dependent variations in T lymphocyte subsets among CNS-TB patients and their clinical implications.
methodsIn this retrospective study, we analysed 862 patients with extrapulmonary tuberculosis (EPTB) admitted to Fuzhou Pulmonary Hospital between April 2018 and April 2024. The cohort comprised 177 CNS-TB patients and a control group of 685 non-central nervous system extrapulmonary tuberculosis (non-CNS EPTB) patients. We comprehensively compared demographic characteristics, medical history, nutritional parameters, T lymphocyte subsets (CD3+, CD4+, CD8+, and CD45+), and neutrophil-to-lymphocyte ratio (NLR) between groups, with detailed age stratification and correlation analyses.
resultsBaseline characteristics, medical history, and nutritional parameters were not significantly different between the groups. CNS-TB patients exhibited markedly reduced T lymphocyte counts, which were most pronounced in the 25–54 year age group (CD3+: 735.5 vs 1010.0 cells/μL, P < 0.001; CD4+: 389.0 vs 576.0 cells/μL, P < 0.001; CD8+: 285.5 vs 358.0 cells/μL, P = 0.013; and CD45+: 1109.5 vs 1448.0 cells/μL, P < 0.001). These differences persisted but attenuated in the 55–64 years age group, with no significant disparities in the 18–24 years and ≥ 65 years age groups. Age-stratified analysis revealed a progressive NLR increase, peaking in patients ≥ 65 years (7.07 vs 4.67, P = 0.010), with diminishing intergroup differences. Correlation analysis revealed strong positive correlations among T-lymphocyte subsets (r = 0.52–0.96, P < 0.001), significant positive correlations with lymphocyte counts (r = 0.52–0.71, P < 0.001) and moderate negative correlations with the NLR (r = − 0.27– -0.37, P < 0.001).
conclusionCNS-TB patients display characteristic T lymphocyte depletion and elevated NLRs, with dynamic age-dependent immune characteristics most prominent in immunocompetent adults. Lymphocyte counts can predict T-cell subset levels, whereas NLR values can predict inflammatory and immune response states. This study provides the first comprehensive demonstration of age-dependent immune characteristics in CNS-TB patients, offering a theoretical foundation for age-stratified immune monitoring strategies. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.